Seroepidemiology of Hepatitis-B surface antigenaemia in HIV positive patients;Les patients séro-épidémiologie de l'hépatite B-antigénémie de surface du VIH positifs

West African Journal of Medicine

Volumn 29, Issue 3, 2010, Pages 169-173

  Balogun, T M ^a   Durojaiye, I O ^a   Sagoe, A ^a   Emmanuel, S ^a  

^a LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

Hepatitis B; HIV positive patients; Seroepidemiology

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODIES, VIRAL; COMORBIDITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 79960881796     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Flewett TH. Can we eradicate hepatitis B. BMJ 1986; 293: 404-405.
2. Bojuwoye. Burden of viral hepatitis in Africa. West Afr J Med 1997; 16: 198-202.
3. Schoub BD. A primer of Hepatitis Serology. VirusSA. 1994; 3: 2.
4. Durosinmi MA, Ndububa DA, Alabi OA, et al. Prevalence of HIV-1 and HBsAg in normal blood donors in Ilelfe, Nigeria. Niger Med J 1992; 21: 138-140.
5. Oronsanye FE, Oronsaye JI. Prevalence of HIV-positives and hepatitis B surface antigen-positives among donors in the University of Benin Teaching Hospital, Nigeria. Trop Doct. 2004; 34: 159-60.
6. Egah DZ, Banwat EB, Audu ES, Iya D, Mandong BM, Anele AA, et al. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. East Mediterr Health J. 2007; 13: 961-6.
7. Otegbayo JA, Fasola FA, Abja A. Prevalence of hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria. Trop Gastroenterol. 2003; 24: 196-197.
8. Obi CL, Anyiwo CE, Nnatu SN, Agbonlahor DE, Esumeh FI, Karpas A. A comparison of human immunodeficiency virus (HIV) seropositivity and hepatitis B surface antigenaemia (HBsAg) among the same group of apparently healthy pregnant women in Lagos, Nigeria: a preliminary. Viral Immunol. 1993; 6: 43-7.
9. Akanmu AS, Esan OA, Adewuyi JO, Davies AO, Okany CC, Olatunji RO, et al. Evaluation of a rapid test kit for detection of HBsAg/eAg in whole blood: a possible method for pre-donation testing. Afr J Med med Sci. 2006; 35: 5-8.
10. Obi CL, Esumeh FI, Igumbor EO, Oyewole F. Olubunmi FA. Prevalence of hepatitis B surface antigen (HBsAg) among apparently healthy human adults seen at the Central Public Health Laboratory, Yaba, Lagos. Cent Afr J Med. 1993; 39: 81-3.
11. WHO. Hepatitis B fact sheet. Revised Oct 2000; No 204.
12. Schoub B D. The hepatitis virus A-G. Virus SA. South Africa. Family Practice, 1995; 3: 1-4.
13. George HeB. Hepatitis Pathogens. A Clinical Guide to Hepatitis. South Africa. Abbot Diagnostics Publications. 1993; 7-11.
14. Thio CL, Seaberg EC, Skolasky RL, Phair J, Visscher B, Munoz A, et al. HIV-1 in multicentre AIDS cohort study (MACS). Lancet 2002; 360: 1921-1926.
15. Rusigi VK, Hoofnagle JH, Gerin GL, Gelmann EP, Richard CM, Cooper JN, et al. Acquired immunodeficiency syndrome. Ann Intern Med 1984; 101: 795-797.
16. Dove L, Wright TL. HIV co-infections with hepatitis viruses in patients with Human Immunodeficiency Virus. Medical Dilemma or inconsequential coincidence. Adv Gastro Hepat Clin Nutr 1997; 1: 231-239.
17. Sirisena ND, Njoku MD, Idoko JA. Hepatitis surface antigenaemia in patients with human immunodeficiency virus-1(HIV-1) infection in Jos, Nigeria. Nig Med Pract 2002; 41: 18-20.
18. Baba MM, Gushau W, Hassan AW. Detection of hepatitis B surface antigenaemia in patients with and without the manifestations of AIDS in Maiduguri, Nigeria. Postgrad Med J 1998; 5: 125-127.
19. Lesi OA, Kehinde MO, Oguh DN, Amira CO. Hepatitis B and C virus infection in Nigerian patients with HIV/ AIDS. Nig Post Med J 2007; 14: 129-132.
20. Ejele OA, Nwauche CA, Erhabor O. The Prevalence of Hepatitis B surface. Antigenaemia in HIV positive patients in the Niger Delta Nigeria. Niger J Med 2004; 13: 175-179.
21. Nwokedi EE, Epopees MA, Dutse AI. Human immunodeficiency virus and hepatitis B virus co-infection among patients in Kano, Nigeria. Niger J Med 2006; 1: 227-229.
22. Seto E, Yen TS, Peter B, Ouj-h Bm. Transcription of the human immunodeficiency virus long terminal repeat by the hepatitis B virus protein. Proc Natl Acad Sci. 1989; 85: 8286-8290.
23. Summary Findings from 2005 HIV/ Syphilis Seroprevalence sentinel survey in Nigeria. Information for policymakers 2005: 30-35.
24. Lagos State Ministry of Health. National HIV/Syphilis Seroprevalence Sentinel Survey among Pregnant Women Attending Antenatal Clinics in Lagos State. Technical Report 2005: 7-20
25. Stud A, Singh J, Dhiman RK, Wanchu A, Singh S, Chawia Y. Hepatitis B virus co-infection in HIV infected patients. Trop Gastroenterol. 2001; 22: 90-92.
26. Sungkanuparph S, Vibhagool A, Manosuthi W, Kiertiburanakul S, Atamasirikul K, Aumkhyan A, et al. Prevalence of hepatitis B virus and hepatitis C co-infection with human immunodeficiency virus in Thai patients: a tertiary case based study. J Med Assoc Thai. 2004; 87: 1349-1354.
27. Lodenyo H, Schoub B, Ally R, Kairu S, Segal I. Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath, Johannesburg. East Afr Med J 2000; 77: 13-15.